Download presentation
Presentation is loading. Please wait.
Published byAgus Sugiarto Modified over 5 years ago
1
Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography
Peter J. Conlon, Mark A. Little, Karen Pieper, Daniel B. Mark Kidney International Volume 60, Issue 4, Pages (October 2001) DOI: /j x Copyright © 2001 International Society of Nephrology Terms and Conditions
2
Figure 1 Kaplan-Meier survival curve showing unadjusted survival according to the presence or absence of significant renal artery stenosis (RAS; P < 0.001). Symbols are: (thick line) <75% RAS; (thin line) ≥75% RAS. Kidney International , DOI: ( /j x) Copyright © 2001 International Society of Nephrology Terms and Conditions
3
Figure 2 Adjusted survival according to the presence or absence of significant renal artery stenosis (RAS) in patients treated with percutaneous transluminal angioplasty (PTCA) (P < 0.001). Symbols are: (thick line) <75% RAS; (thin line) ≥75% RAS. Kidney International , DOI: ( /j x) Copyright © 2001 International Society of Nephrology Terms and Conditions
4
Figure 3 Adjusted survival according to the presence or absence of significant renal artery stenosis (RAS) in patients treated with coronary artery bypass graft (CABG) (P < 0.001). Symbols are: (thick line) <75% RAS; (thin line) ≥75% RAS. Kidney International , DOI: ( /j x) Copyright © 2001 International Society of Nephrology Terms and Conditions
5
Figure 4 Adjusted survival stratified for the severity of renal artery stenosis (RAS) (P < for trend). Symbols are: (thick line) 10 to 75% RAS; (medium line) 75 to 95% RAS; (thin line) ≥95% RAS. Kidney International , DOI: ( /j x) Copyright © 2001 International Society of Nephrology Terms and Conditions
6
Figure 5 Adjusted survival according to the presence of unilateral (thick line) or bilateral (thin line) renal artery stenosis (RAS) (P < 0.001). Kidney International , DOI: ( /j x) Copyright © 2001 International Society of Nephrology Terms and Conditions
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.